The Hi-Tech Gears Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 9:42 am

Competitors of The Hi-Tech Gears Ltd

All Competitor Stocks of The Hi-Tech Gears Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:25 am

Below is a detailed analysis of the quarterly data for The Hi-Tech Gears Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 215.55 Cr.. The value appears strong and on an upward trend. It has increased from 214.88 Cr. (Mar 2025) to 215.55 Cr., marking an increase of 0.67 Cr..
• For Expenses, as of Jun 2025, the value is 189.40 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 181.66 Cr. (Mar 2025) to 189.40 Cr., marking an increase of 7.74 Cr..
• For Operating Profit, as of Jun 2025, the value is 26.15 Cr.. The value appears to be declining and may need further review. It has decreased from 33.22 Cr. (Mar 2025) to 26.15 Cr., marking a decrease of 7.07 Cr..
• For OPM %, as of Jun 2025, the value is 12.13%. The value appears to be declining and may need further review. It has decreased from 15.46% (Mar 2025) to 12.13%, marking a decrease of 3.33%.
• For Other Income, as of Jun 2025, the value is 4.55 Cr.. The value appears strong and on an upward trend. It has increased from 4.30 Cr. (Mar 2025) to 4.55 Cr., marking an increase of 0.25 Cr..
• For Interest, as of Jun 2025, the value is 3.79 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.34 Cr. (Mar 2025) to 3.79 Cr., marking a decrease of 0.55 Cr..
• For Depreciation, as of Jun 2025, the value is 16.40 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.93 Cr. (Mar 2025) to 16.40 Cr., marking an increase of 0.47 Cr..
• For Profit before tax, as of Jun 2025, the value is 10.51 Cr.. The value appears to be declining and may need further review. It has decreased from 17.25 Cr. (Mar 2025) to 10.51 Cr., marking a decrease of 6.74 Cr..
• For Tax %, as of Jun 2025, the value is 42.91%. The value appears to be improving (decreasing) as expected. It has decreased from 43.65% (Mar 2025) to 42.91%, marking a decrease of 0.74%.
• For Net Profit, as of Jun 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.72 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 3.72 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.19. The value appears to be declining and may need further review. It has decreased from 5.17 (Mar 2025) to 3.19, marking a decrease of 1.98.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:18 am

Growth

Last Updated: September 5, 2025, 1:45 pm

Balance Sheet

Last Updated: November 9, 2025, 3:06 pm

Below is a detailed analysis of the balance sheet data for The Hi-Tech Gears Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00 Cr..
• For Reserves, as of Sep 2025, the value is 480.00 Cr.. The value appears strong and on an upward trend. It has increased from 465.00 Cr. (Mar 2025) to 480.00 Cr., marking an increase of 15.00 Cr..
• For Borrowings, as of Sep 2025, the value is 181.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 202.00 Cr. (Mar 2025) to 181.00 Cr., marking a decrease of 21.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 133.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 118.00 Cr. (Mar 2025) to 133.00 Cr., marking an increase of 15.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 813.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 804.00 Cr. (Mar 2025) to 813.00 Cr., marking an increase of 9.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 438.00 Cr.. The value appears to be declining and may need further review. It has decreased from 445.00 Cr. (Mar 2025) to 438.00 Cr., marking a decrease of 7.00 Cr..
• For CWIP, as of Sep 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 5.00 Cr..
• For Investments, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Other Assets, as of Sep 2025, the value is 368.00 Cr.. The value appears strong and on an upward trend. It has increased from 357.00 Cr. (Mar 2025) to 368.00 Cr., marking an increase of 11.00 Cr..
• For Total Assets, as of Sep 2025, the value is 813.00 Cr.. The value appears strong and on an upward trend. It has increased from 804.00 Cr. (Mar 2025) to 813.00 Cr., marking an increase of 9.00 Cr..

Notably, the Reserves (480.00 Cr.) exceed the Borrowings (181.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for The Hi-Tech Gears Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 21.49. This value is within the healthy range. It has decreased from 60.86 (Mar 24) to 21.49, marking a decrease of 39.37.
• For Diluted EPS (Rs.), as of Mar 25, the value is 21.46. This value is within the healthy range. It has decreased from 60.73 (Mar 24) to 21.46, marking a decrease of 39.27.
• For Cash EPS (Rs.), as of Mar 25, the value is 55.25. This value is within the healthy range. It has decreased from 93.42 (Mar 24) to 55.25, marking a decrease of 38.17.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 257.32. It has increased from 248.24 (Mar 24) to 257.32, marking an increase of 9.08.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 257.32. It has increased from 248.24 (Mar 24) to 257.32, marking an increase of 9.08.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 493.25. It has decreased from 589.47 (Mar 24) to 493.25, marking a decrease of 96.22.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 78.54. This value is within the healthy range. It has decreased from 85.14 (Mar 24) to 78.54, marking a decrease of 6.60.
• For PBIT / Share (Rs.), as of Mar 25, the value is 44.77. This value is within the healthy range. It has decreased from 52.56 (Mar 24) to 44.77, marking a decrease of 7.79.
• For PBT / Share (Rs.), as of Mar 25, the value is 33.40. This value is within the healthy range. It has decreased from 73.45 (Mar 24) to 33.40, marking a decrease of 40.05.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 21.48. This value is within the healthy range. It has decreased from 60.84 (Mar 24) to 21.48, marking a decrease of 39.36.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 21.48. This value is within the healthy range. It has decreased from 60.84 (Mar 24) to 21.48, marking a decrease of 39.36.
• For PBDIT Margin (%), as of Mar 25, the value is 15.92. This value is within the healthy range. It has increased from 14.44 (Mar 24) to 15.92, marking an increase of 1.48.
• For PBIT Margin (%), as of Mar 25, the value is 9.07. This value is below the healthy minimum of 10. It has increased from 8.91 (Mar 24) to 9.07, marking an increase of 0.16.
• For PBT Margin (%), as of Mar 25, the value is 6.77. This value is below the healthy minimum of 10. It has decreased from 12.46 (Mar 24) to 6.77, marking a decrease of 5.69.
• For Net Profit Margin (%), as of Mar 25, the value is 4.35. This value is below the healthy minimum of 5. It has decreased from 10.32 (Mar 24) to 4.35, marking a decrease of 5.97.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.35. This value is below the healthy minimum of 8. It has decreased from 10.32 (Mar 24) to 4.35, marking a decrease of 5.97.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.34. This value is below the healthy minimum of 15. It has decreased from 24.50 (Mar 24) to 8.34, marking a decrease of 16.16.
• For Return on Capital Employeed (%), as of Mar 25, the value is 13.59. This value is within the healthy range. It has decreased from 16.05 (Mar 24) to 13.59, marking a decrease of 2.46.
• For Return On Assets (%), as of Mar 25, the value is 5.01. This value is within the healthy range. It has decreased from 12.57 (Mar 24) to 5.01, marking a decrease of 7.56.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.26. This value is within the healthy range. It has increased from 0.11 (Mar 24) to 0.26, marking an increase of 0.15.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.41. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.41.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.08. It has decreased from 1.17 (Mar 24) to 1.08, marking a decrease of 0.09.
• For Current Ratio (X), as of Mar 25, the value is 1.86. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.86, marking an increase of 0.44.
• For Quick Ratio (X), as of Mar 25, the value is 1.19. This value is within the healthy range. It has increased from 0.99 (Mar 24) to 1.19, marking an increase of 0.20.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.63. This value is below the healthy minimum of 4. It has decreased from 4.44 (Mar 24) to 3.63, marking a decrease of 0.81.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 4.10 (Mar 24) to 0.00, marking a decrease of 4.10.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.67 (Mar 24) to 0.00, marking a decrease of 2.67.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 95.90 (Mar 24) to 0.00, marking a decrease of 95.90.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.33 (Mar 24) to 0.00, marking a decrease of 97.33.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.91. This value is within the healthy range. It has increased from 4.23 (Mar 24) to 6.91, marking an increase of 2.68.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.89. This value is below the healthy minimum of 3. It has increased from 1.99 (Mar 24) to 2.89, marking an increase of 0.90.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,303.43. It has decreased from 1,583.85 (Mar 24) to 1,303.43, marking a decrease of 280.42.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.41. This value is within the healthy range. It has decreased from 1.43 (Mar 24) to 1.41, marking a decrease of 0.02.
• For EV / EBITDA (X), as of Mar 25, the value is 8.83. This value is within the healthy range. It has decreased from 9.91 (Mar 24) to 8.83, marking a decrease of 1.08.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has decreased from 1.30 (Mar 24) to 1.23, marking a decrease of 0.07.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 95.89 (Mar 24) to 0.00, marking a decrease of 95.89.
• For Price / BV (X), as of Mar 25, the value is 2.35. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 2.35, marking a decrease of 0.75.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has decreased from 1.30 (Mar 24) to 1.23, marking a decrease of 0.07.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.03, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness